Everence Capital Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16M Sell
5,634
-518
-8% -$103K 0.06% 232
2026
Q2
$1.15M Buy
6,152
+750
+14% +$110K 0.06% 232
2026
Q1
$525K Buy
5,402
+772
+17% +$78K 0.03% 364
2025
Q4
$369K Hold
4,630
– – 0.02% 508
2025
Q3
$216K Buy
+4,630
New +$181K 0.01% 743
2025
Q1
– Sell
-4,630
Closed -$203K – 833
2024
Q4
$203K Buy
+4,630
New +$234K 0.01% 779

Other funds holding RVMD

Everence Capital Management's RVMD Position: Q3 2026 in Review

Everence Capital Management reduced its Revolution Medicines (RVMD) stake by 8.4% in Q3 2026, selling an estimated $103K and leaving 5,634 shares worth $1.16M. The position accounts for 0.06% of the portfolio, ranked #232.

Everence Capital Management first reported a position in RVMD in Q4 2024 and has held it in 6 quarters since. 749 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Everence Capital Management held 5,634 shares of Revolution Medicines worth $1.16M as of Q3 2026.
  • Everence Capital Management sold 518 Revolution Medicines shares in Q3 2026, an estimated $103K.
  • Revolution Medicines made up 0.06% of Everence Capital Management's portfolio in Q3 2026, its #232 holding.
  • Everence Capital Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 6 quarters since.
  • 749 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.